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Abstract 
Entamoeba histolytica has been separated in recent years into 2 morphologically identical species: the 
apathogenic E. dispar and the pathogenic E. histolytica, only the latter being pathogenic. Although various 
laboratory techniques allow discrimination between the 2 species there is a lack of field data about the 
suitability of available diagnostic tests for use in epidemiological studies and few epidemiological studies 
using species-specific diagnosis have been performed at community level in endemic areas, especially in 
sub-Saharan Africa. We conducted a repeated cross-sectional study of 967 schoolchildren in central Cbte 
d’Ivoire to compare and evaluate light microscopy, 2 different antigen detection assays, and one 
polymerase chain reaction (PCR) assay. Microscopy and a non-specific antigen capture Entamoeba 
enzyme-linked immunosorbent assay (ELISA) were used for the primary screening of all children (time 
to). The prevalence of the E. histolytica/E. dispar species complex at to was 18.8% by single microscopical 
examination and 31.4% using the non-specific ELISA. Approximately 2 months after the initial screen- 
ing, fresh stool specimens were collected on 2 consecutive days (tl and t2) from (i) all the children who 
were positive by microscopy at to (n = 182) and (ii) 155 randomly selected children who were negative at 
the primary screening. These samples were tested with a second antigen detection ELISA specific for E. 
histolytica (n = 238) and with a species-specific PCR assay (n = 193). The second and third examinations 
(tl and t2) revealed an additional 43 infections with the species complex E. histolytica/E. dispar, so that the 
cumulative microscopical prevalence for t, and t2 was 27.7%. The overall prevalence of E. histolytica by 
species-specific ELISA antigen detection was low (0.83%), while the prevalence of E. dispar was 15%. 
When analysing only microscopically positive samples by PCR (n = 129), the ratio E. histolytica:E. dispar 
was very low (1:46), suggesting that the vast majority of Entamoeba infections in this area were 
apathogenic. Both species-specific tests performed well but the ELISA was easier to use for large-scale 
field screening. 
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Introduction 
It is now generally accepted that there are 2 geneti- 
cally distinct but morphologically indistinguishable spe- 
cies of Entamoeba, E. histolytica and E. dispar (see 
DIAMOND & CLARK, 1993). Only E. histolytica has the 
potential to cause dysentery and extra-intestinal dis- 
ease; E. dispar is considered to be a harmless commen- 
Sal. The World Health Organization has reaffirmed the 
definition of amoebiasis as infection with E. histolytica 
sensu stricto, with or without clinical manifestation, and 
recommended that ‘E. histolytica should be specifically 
identified and, if present, treated; if only E. dispar is 
identified, treatment is unnecessary’ (ANONYMOUS, 
1997). 
The diagnosis of E. histolytica has traditionally relied 
upon microscopical examination of fresh or fixed stool 
specimens. A number of epidemiological studies had 
been performed before the clear distinction of the 2 
species was established. Because they are microscopi- 
cally indistinguishable, the validity of studies based on 
stool surveys only has been questioned. The frequently 
quoted statistics of 40 million to 50 million people 
infected and up to 100 000 dying of amoebiasis world- 
wide are based in large part on these parasitological 
surveys, and this has led to an unclear picture of the 
epidemiology of amoebiasis (WALSH, 1986; ANONY- 
MOUS, 1997). 
In recent years, several alternative diagnostic meth- 
ods have been developed for the differentiation of the 2 
species: isoenzyme typing (SARGEAUNT et al., 1978, 
1987), deoxyribonucleic acid (DNA) probes for use 
with the polymerase chain reaction (PCR) and restric- 
tion endonuclease pattern analysis (TANNICH & 
BURCHARD, 1991; ROMERO et al., 1992; KATZWIN- 
KEL-WLADARSCH et al., 1994; TROLL et al., 1997), and 
enzyme-linked immunosorbent assav (ELISA) antigen- 
detection systems based on mon&lonal antibo‘hies 
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(ABD-ALLA et al., 1993; HAQUE et al., 1994). Cultiva- 
tion of amoebae followed by isoenzyme analysis is a 
standard method of differentiation of E. histolytica and 
E. dispar. However, this method is time-consuming, 
not widely available and essentially impractical for 
large-scale epidemiological studies. PCR amplification 
of ribosomal ribonucleic acid (rRNA) genes of Enta- 
moeba spp., as well as a new ELISA directed against the 
GaliGalNAc lectin (produced by TechLab Inc., 
Blacksburg, VA, USA) have been reported to approach 
the sensitivity and specificity of isoenzyme analysis in 
detecting E. histolytica directly in stool samples of 
symptomatic patients (HAQUE et al., 1995, 1998). 
However, a comparative study using cultured parasites 
as the source of DNA and antigen showed that the 
PCR was more sensitive than antigen detection by 
ELISA (MIRELMAN et al., 1997). 
Given the current paucity of reliable data on the 
worldwide distribution of E. histolytica and E. dispar, it 
is critically important to arrive at better estimates of the 
burden of E. histolytica infection by using improved 
diagnostic tests. In sub-Saharan Africa only a few epi- 
demiological surveys using species identification by 
isoenzyme analysis have been conducted, in South 
Africa (JACKSON et al., 1982; GATHIRAM & JACKSON, 
1985, 1987) and Ethiopia (GATTI et al., 1998). Infor- 
mation is crucial for the clinical and public health 
management of the disease, at both national and global 
levels. Moreover, adequate diagnostic methods and 
epidemiological information are urgently needed in 
view of the recent developments towards an amoebiasis 
vaccine (STANLEY, 1997; HUSTON & PETRI, 1998). 
Obtaining further species-specific prevalence data on 
amoebiasis and the development of field testing strate- 
gies are therefore of high priority. 
Based on previous wo;k in 68te d’Ivoire revealing a 
high prevalence of the E. histoZvticalE. disaar comolex 
(&ZINGER et al., 1999), the 0‘6jectives of the present 
study were (i) to assess the prevalence of the complex 
in children in CBte d’Ivoire using a newly available 
522 
ELISA and repeated microscopy, (ii) to identify E. 
histolvtica suecificallv usinn an established PCR assav 
(TROLL et al., 1997) and in antigen detection ELISA 
test, and (iii) to compare the diagnostic performance of 
these tests. 
Materials and Methods 
Study area and population surveyed 
The study was carried out near the town of Agboville 
in the south of CBte d’Ivoire between March and June 
2000. All schoolchildren attending standards 4-6 at 8 
randomly selected primary schools in the Agboville 
school district were enrolled. The objectives of the 
study were discussed with the school directors and, 
after obtaining their consent, the sex and age of the 
children were recorded. The day before the first survey, 
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children were issued with a small plastic container and 
asked to return the containers with a small portion of 
their morning stool. After stool collection, children 
were issued with a new container for the following 
sample collection. In total 3 stool samples were col- 
lected, at time to at the beginning of the study, and at 
times t, and tz, approximately 2 months after to (Fig. 1). 
Identification of E. histolytica/E. dispar complex infections 
The stool specimens were taken to the laboratory in 
Abidjan within 3 h after collection. Before being further 
processed, each specimen was examined macroscopi- 
tally for consistency with special emphasis on liquid 
specimens and on blood visible by eye. 
A total of 967 stool samples was collected at time to, 
and a l-2 g portion was preserved in sodium acetate- 
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Fig. 1. Screening procedure for 967 schoolchildren in C6te d’Ivoire for detection of the Entamoeba histolytica/E. dtipar complex and 
specific identification of the parasites. Numbers in circles indicate collection of fresh stool specimens. 
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acetic acid-formalin (SAF). The samples were exam- 
ined after processing according to MARTI & ESCHER 
(1990) by light microscopy within 6 weeks (Fig. 1). All 
samples containing E. histolyticalE. dispar and other 
protists and helminths were recorded semi-quantita- 
tively by distinguishing between 3 levels: 1+ = 1-5 
parasites seen per slide; 2+ = l-2 parasites seen per 
microscope field; 3+ = more than 2 parasites per mi- 
croscope field. Microscopical examination was done by 
one of 3 skilled and experienced laboratory technicians. 
Slides containing cysts or trophozoites of E. histolyticai 
E. dispar were systematically checked and confirmed by 
a second technician. 
A single Kato-Katz thick smear was also prepared 
from the stool samples collected at to, according to 
KATZ et al. (1972). The slides were examined by light 
microscopy and all helminth eggs were identified and 
recorded quantitatively. 
Approximately 2 months after the first screening, 
155 fresh stool samples were collected from a random 
selection of previously microscopically negative chil- 
dren on 2 consecutive days (times t, and tz), processed 
as described above and examined by light microscopy 
during the following 3 weeks. These 2 repeat examina- 
tions allowed the comparison of repeated microscopical 
examinations with the ‘Entamoeba’ ELISA. The results 
of examinations at to and t,lt, were not pooled for 
analysis because of the risk of new infections occurring 
during the 2 months interval between to and t, lt2. 
Antigen detection ELBA 
A randomly selected sample of 327 specimens of the 
initial 967 stool samples was tested at to with the 
‘Entamoeba’ antigen capture ELISA, to detect the Gal/ 
GalNAc lectin of both E. histolytica and E. dispar. 
Additionally, and for comparison with repeated micro- 
scopical samples, 46 of the initially microscopically 
negative specimens were also tested at t,/t, by the 
‘Entamoeba’ ELISA. The tests were performed accord- 
ing to the manufacturer’s instructions (TechLab Inc.) 
and the optical density was measured with an auto- 
matic photometer at 450 nm. 
Species-specific testing 
Species-specific diagnosis was done with the aid of 
(i) a PCR assay developed by TROLL et al. (1997) and 
(ii) the ‘Histolytica’ ELISA antigen capture test (Tech- 
Lab Inc.) using stool specimens of children found to be 
infected with E. histolytica/E, dispar at the first micro- 
scopical examination (to) and samples from randomly 
selected microscopically negative children (Fig. 1). 
Due to problems in tracing children and also some- 
times to insufficient material in the samples, the num- 
bers of specimens tested by the 2 species-specific tests 
differed. The PCR targets rRNA genes of both E. 
histolytica and E. dispar in 2 separate reactions and 
therefore allows positive identification of both species. 
By contrast, the ‘Histolytica’ antigen detection ELISA 
is specific only for E. histolytica adhesin. 
PCR assay 
After initial concentration in SAF fixative the result- 
ing pellets were washed 3 times with distilled water, 
transferred to 1.5 mL Eppendorf tubes, and suspended 
in 250 pL digestion buffer (100 mM Tris, pH 8.0; 
25 mM ethylenediaminetetraacetic acid). The samples 
were then frozen and transported to Switzerland for 
further analysis. Subsequent analysis of the samples 
was done accordina to TROLL et al. (1993). with the 
following modificaGons: (i) DNA was ou&ed after 
extraction using the QIAamp tissue mini-kit (Qiagen 
AG, Switzerland) in order to eliminate PCR inhibitors: 
(ii) the purified DNA was used without dilution in the 
PCR; (iii) deoxythymidine triphosphate was used in- 
stead of deoxyuridine triphosphate; (iv) restriction en- 
donuclease (DraI) digests were performed on only a 
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small number of E. dispar samples, in particular those 
showing faint bands, in order to confirm the identity of 
the amplified fragment. 
‘Histolytica’ antigen detection test 
In this assay E. histolytica is specifically identified due 
to differences in the Gal/GalNAc lectin between E. 
histolytica and E. dispar (see HAQUE et al., 1995). The 
tests were performed according to the manufacturer’s 
instructions (TechLab Inc.). 
Chemotherapy 
Treatment for intestinal helminth and protozoan 
parasites was given to all children found to be infected 
according to the C&e d’Ivoire national guidelines. 
Medication and doses used were approved by the Chief 
Medical Officer of the Agboville Health Department 
and administered by a pharmacist of the local Health 
Department. E. histolyticalE. dispar and Giardia duode- 
nalis infections were treated with 3 daily doses of 
metronidazole (10 mg/kg bodyweight) for 8 d. Infec- 
tions with Schistosoma mansoni were treated with a 
single dose of praziquantel (40 mg/kg bodyweight) and 
all other helminths (i.e. Ascarik Zumbrkoides, Trkhurik 
trichiuru, hookworms) with a single dose of albenda- 
zole. 
All results of the microscopical examination and all 
data from the other diagnostic assays were double- 
entered into the ExcelT” 1997 software package. After 
transfer to the FoxproT” 2.6 database, frequency and 
consistency tests were carried out. Analysis of associa- 
tions and diagnostic performance calculations were 
carried out with the STATAT” 7.0 statistics package 
(Stata Corporation, College Station, Texas, USA). 
Results 
Parasitology and non-specific ELISA 
Complete results for the first microscopical examina- 
tion were obtained for 967 children (90% of the en- 
rolled children). The median age was 12 years with a 
range from 8 to 16 years. There were significantly more 
boys (n = 589) than girls (n = 378) (a = 38.8, 
P < 0.001). Macroscopic stool examination revealed 
574 liquid/unformed specimens (59%). Only 5 children 
presented specimens containing macroscopically de- 
tectable blood, of which only one was subsequently 
shown to harbour E. histolvtica/E. disaar bv microsconv. 
There was no association between liquid/unformed 
specimens and infection with E. histolyticalE. dispar 
yclt; ratio = 1.13, 95% confidence interval (CI) 0.82- 
The point prevalence of E. histoZytica/E. dispar for the 
single microscopical examination at tn was 18.8% (1821 
967; 95% CI 16.4-21.4). Most of the children infected 
with E. histolvtica/E. disaar showed infection levels of 
1+ (83%). The predomhant protozoan parasite was E. 
coli with a prevalence of 63.4%. Prevalences for all 
protozoa are presented in Table 1. 
The combined results from the single Kato-Katz 
thick smear and the first microscopical examination 
showed that hookworms and S. mansoni were the 
commonest helminths (Table 1). 
The non-specific ‘Entamoeba’ antigen detection 
ELISA was performed on a total of 327 specimens 
randomly selected from the initial 967 (Fig. 1). The 
parasitological prevalence of E. histoZytica/E. dispar in- 
fections within this sample based on a single micro- 
scopical examination was 18.7% (61/327), which is 
close to the prevalence of 18.8% found in the overall 
sample of 967 children. The ‘Entamoeba’ ELISA de- 
tected 103 positive cases, giving a higher prevalence 
rate of 31.5% (103/327; 95% CI 26.5-36.8). 
Stool specimens of 155 children who were negative 
at to were collected again at t, . At tz, one day later, only 
103 of them were present. These later examinations 
revealed an additional 43 infections with the E. histoly- 
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Table 1. Prevalence of intestinal protozoa among 967 schoolchildren in 
CBte d’Ivoire screened by direct stool microscopy” and intestinal hehninths 
among 885 children screened by direct microscopy” and a single Kato-Katz 
thick smear 
Intestinal parasite 
No. of infected 
children Prevalence ( %)b 
Protozoa 
Entamoeba histolyticaiEntamoeba dispar 
Entamoeba coli 
182 18.8 (16.4-21.4) 
613 63.4 (60.6-66.81 
Giardia duodenalis 8.0 {6.3-9.9) ’ 
Endolimax nana 4::: 46.2 (43.3-49.7) 
Chilomastix mesnili 98 10.1 (8.3-12.3) 
Entamoeba hartmanni 126 13.0 (11.0-15.4) 
Iodamoeba buetschlii 85 8.8(7.1-10.8) 
Blastocystis hominis 81 8.4 (6.7-10.4) 
Helminths 
Schistosoma mansoni 189 21*4(18*7-24.2) 
Hookworm 271 30.6(27*6-33.8) 
Ascark lumbricoides 78 8.8 (7.0-10.9) 
Trichurik trichiura 85 9.6(7.7-11.7) 
BUsing sodium acetate-acetic acid-fonnalin fLvation (MARTI & ESCHER, 1993). 
b95% Confidence interval in parentheses. 
ticalE. dispar species complex; the cumulative preva- 
lence for t, and tz was 27.7%. 
Species-spec$c testing 
152 and 129 samples which were positive at to were 
tested with the specific ‘Histolytica’ ELISA and the 
PCR, respectively (Fig. 1). The set of samples tested by 
the 2 assays did not overlap completely due to problems 
in sample preparation. The ‘Histolytica test’ detected 
3/152 E. histolytica infections (2.0%; 95% CI 0.7-5.6) 
and the PCR test 2/129 (1.6%; 95% CI 0.4-5.5). E. 
dispar was detected by the PCR in 93 of the 129 
samples tested (72.1%; 95% CI 63.8-79.1). 34 of the 
129 samples found to be positive by microscopy were 
negative by PCR (26.4%; 95% CI 19.5-34.6). Based 
on PCR results with the microscopically positive sam- 
ples, the species ratio E. histolytica:E. dispar was c. 1:46. 
No additional E. histolytica case was detected by the 
‘Histolytica’ test or by the PCR when testing the micro- 
scopically negative samples. 
Pe$ormance of diagnostic tests: non-specific tests 
Using isoenzyme analysis as the reference test, the 
‘Entamoeba’ antigen detection assay has been shown to 
be more sensitive (80% vs. 60%) and more specific 
(99% vs. 79%) than microscopy (HAQUE et al., 1995). 
We therefore used the results of the ‘Entamoeba’ test to 
evaluate single and repeated microscopical examination 
(Table 2). Single microscopical examination of a stool 
sample collected at to was moderately sensitive (68.9%; 
95% CI 56.4-79.1) and specific (77.1%; 95% CI 
71.7-81.7). Repeated microscopical examination on 2 
consecutive days at t, and t2 improved sensitivity 
(77.8%; 95% CI 54.8-91.0) and specificity (89.3%; 
95% CI 72*8-96*3), although this was measured on a 
much smaller sample (n = 46 compared with n= 327), 
which is reflected in the much wider 95% confidence 
intervals. If we had taken single microscopy as refer- 
ence standard, the sensitivity of the ‘Entamoeba’ test 
would have been only 40.8% (95% CI 31.8-50.4) and 
the specificity would have been 91.5% (95% CI 87.1- 
94.5). With repeated microscopical examination as 
reference at t, and t2, the sensitivity of the ‘Entamoeba’ 
test would have been 82.4% (95% CI 59.0-93.8) and 
th.e specificity would have been 86.2 % (95% CI 69*4- 
94*5), again on a much smaller sample. 
We also compared the ‘Entamoeba’ ELISA with the 
PCR, combining the PCR results for E. histolytica and 
E. dispar. In total, 101 specimens were examined by 
both PCR and the ‘Entamoeba’ test. PCR and the 
‘Entamoeba’ test detected 75 and 53 E. histolytica/E. 
dispar infections, respectively (Fig. 2). The agreement 
Table 2. Sensitivity and specificity of one and two consecutive microscopi- 
cal stool examinations for the detection of the Entamoeba histolyticalE. 
dispar complex compared with the non-species-specific enzyme-linked 
immunosorbent assay 
ELISA” 
Microscopy Positive Negative Total 
Single examinationb 
Positive 
Negative 
Total 
Two examinationsbjc 
Positive 
Negative 
Total 
42 61 103 
19 205 224 
61 266 327 
14 3 
1: Es 
ii 
46 
“Enzyme-linked immunosorbent assay for Emamoeba sp. 
Wsing sodium acetate-acetic acid-formalin futation (MARTI L? ESCHER, 1993). 
‘On consecutive days, approximately 2 months after the single examination. 
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Fig. 2. Optical density (OD) values for the Enrumoeba enzyme-linked immunosorbent assay (ELISA) of stool specimens tested 
previously by the polymerase chain reaction @‘CR): (A) 26 PCR-negative samples; (B) 75 PCR-positive samples. The small inserts 
show the same data for a narrower OD range and the OD positivity cut-off value of the Entamoeba ELISA (OD = 0.05); white bars 
indicate concordance between the PCR and ELISA results, shaded bars indicate discordance. 
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of the 2 tests in detecting positives was only 46.5% 
(95% CI 36.5%-56.7%). 
Pe$ornaance of diagnostic tests: species-specific tests 
185 specimens were tested with both the ‘Histolytica’ 
antigen detection ELISA and the PCR. The microsco- 
pical prevalence of the E. histoZytica/E. dispar complex 
in this sample was 76.8% (142/185; 95% CI 70.2- 
82.3). Both specific assays detected only a small num- 
ber of E. histolytica infections; 3 by the specific antigen 
detection ELISA and 2 by the PCR (Table 3). Of the 3 
E. histoZytica cases detected by ELISA, the PCR result 
agreed in one case and identified the remaining 2 speci- 
mens as containing E. dispar. The remaining positive 
sample detected by PCR was positive for both E. 
histolytica and E. dispar but was found to be negative by 
the ‘Histolytica’ antigen detection ELISA. As a quality 
control measure, the samples found to be positive for 
E. histolytica by either PCR (n = 2) or ‘Histolytica’ 
ELISA (n = 3) were re-examined by PCR by an inde- 
pendent investigator. The second examination con- 
firmed all the results. Using the PCR as reference 
standard, the specific antigen detection ELISA exhib- 
ited an overall test efficiency (proportion of true posi- 
tives and true negatives) of 98.4% (95% CI 95.3- 
99.4). 
Discussion 
The high endemicity of E. histolyticalE. dispar in Cote 
d’Ivoire was confirmed by the present study with 
schoolchildren, who had an infection prevalence of 
18.8% derived from a single microscopical examination 
and one of 31.4% with the ‘Entamoeba’ ELISA. The 
second and third microscopical examinations per- 
formed revealed a considerable number of additional 
infections but we did not consider these cumulatively 
because we could not exclude reinfections in the period 
of 2 months between the first and the second specimen 
collections. These prevalence estimates are conserva- 
tive because of the probability of missing cases with a 
single examination. 
However, the difference between the prevalence rates 
at t, and t2 exemplifies the problem of lack of sensitivity 
of a single microscopical examination. It has been 
shown by other workers that a single examination of 
formalin-fixed stool fails to identifv all infections. In a 
laboratory-based study (MARTI & +KOELLA, 1993), ex- 
amination of 3 stool samples fixed in SAF resulted in 
92% sensitivity when identifying E. histolyticalE. dispar; 
98% sensitivity was achieved only after >4 examina- 
tions. Other reports have highlighted the need to exam- 
ine 3 or more formalin-fixed stool specimens on 
separate days to detect >80-90% of infections because 
of intermittent shedding of cysts (KNIGHT, 1974; JUNI- 
PER, 1978). 
By using the SAF sedimentation technique we re- 
duced the risk of false positive diagnoses due to confu- 
sion of leucocytes and macrophages with amoebic cysts 
and trophozoites, as previously reported with examina- 
tion of direct smears (KNIGHT, 1974). However, mis- 
identification of other protozoa as E. histolyticalE. 
dispar cysts may have influenced the specificity of our 
detection. The risk of confounding immature E. coli 
cysts with those of E. histolyticalE. dispar is real, espe- 
cially when differential morphological features such as 
chromatoid bodies are absent. This issue is of particular 
importance since both E. colt’ and E. histolyticalE, dispar 
are generally found in the same areas with poor hygie- 
nic conditions, and E. coli is usually the more prevalent 
species. 
Other field-based studies in West Africa, relying on 
single examinations of formalin-ether concentrated 
stool specimens, also found high prevalences of E. 
histolytica/E. dispar (52.3% and 37%; BRAY & HARRIS, 
1977 and UTZINGER et aZ., 1999, respectively). In 
contrast, community-based surveys in other endemic 
areas, using similar diagnostic methods, reported sub- 
stantially lower prevalence rates. A study in South 
Africa examined 800 specimens and found the preva- 
lence of the species complex to be only 28% (GATHIR- 
AM & JACKSON, 1985). In south-east Asia and in 
Mexico, E. histolytica/E. dispar infection rates of 12.4% 
and 8.1% have been reported (ACUNA-SOTO et al., 
1993; RIVERA et al., 1998). In numerous other studies, 
prevalences of E. histolytica/E. dispar were mostly based 
on examination of direct smears and’or the surveys 
were hospital-based rather than community-based, and 
therefore cannot be compared easily with our findings. 
This is the first community-based study looking at 
soecies-snecific nrevalence of E. histolvtica and E. disaar 
in sub-Saharan-Africa using diagno&c methods other 
than isoenzyme analysis. E. histolytica infections were 
assessed separately by a PCR assay and the ‘Histolytica’ 
ELISA antigen detection test developed by Techlab 
Inc. Among specimens shown microscopically to con- 
tain E. histolyticalE. dispar, both species-specific tests 
detected a surprisingly low number of E. histolytica 
infections (2 by the PCR assay, including one sample 
with both E. histolytica and E. dispar, and 3 by the non- 
specific ELISA antigen detection test). As expected, 
PCR identified most of the remaining samples as E. 
dispar, leading to a low species ratio of E. histolytica to 
E. dispar of 1:46. 
It could be argued that by testing only the subjects 
found to be infected at the first microscopical examina- 
tion, the prevalence of infection might not be properly 
reflected. However, given the fact that no further E. 
histolytica case was discovered in a sample of 86 micro- 
scopically negative samples tested by ELISA and 64 
microscopically negative samples tested by PCR, we 
are reasonably confident that our ratio of 1:46 is accu- 
rate. This finding contrasts with most other surveys 
using the approach of pre-selecting E. histoZytica/E. 
dispar infections by a non-specific test followed by the 
differentiation of the species, which found considerably 
lower proportions of E. dispar (Table 4). 
On the basis of the small number of community- 
based studies which involved species-specific diagnosis, 
Table 3. Comparison of species-specific Entamoeba histolytica antigen 
detection enzyme-linked immunosorbent assay and the polymerase chain 
reaction among 185 infected schoolchildren in C6te d’Ivolre 
Polymerase chain reaction 
Positive Negative 
Species-specific ELISA” 
Positive 1 2 
Negative lb 181 
Total 2 183 
“Enzyme-linked immunosorbent assay. 
bSpecimen positive for both Entamoeba histolytica and E. dispar. 
Total 
3 
182 
185 
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Table 4. Reported prevalence rates and ratios for Entamoeba histolytica and E. dispar in amoebiasis 
endemic areas 
Area Reference 
Turkey JETTER et al., 1997 
South Africa JACKSON et al., 1982 
Mexico ACUNA-SOTO et al., 1993 
Philippines RIVERA et al., 1998 
Bangladesh HAQUE et al., 1997 
Bangladesh HAQUE et al., 1998 
Cote d’Ivoire This study 
Diagnostic 
method” 
PCR 
Isoenzymes 
PCR 
PCR 
ELISA 
ELISA 
ELISA & PCR 
Prevalence (%)b 
31.6 (73/231) 
10.0 (13911381) 
12.4 (25/201) 
8.1 (152/1872) 
8.0 (79/987) 
17.4 (1181680) 
31.5 (103/327) 
Species ratio’ 
E. dispar only 
1:lO 
Noted 
1:8.5 
1:8 
1:2*7 
I:46 
“ELISA = enzyme-linked immunosorbent assay; PCR = polymerase chain reaction. 
bE. histolyticalE. dispar complex. 
‘E. histolytiia:E. dispar. 
d56% of all individuals infected harboured mixed infections with E. histolytica and E. dispar. 
it appears that the species ratio E. histoZytica:E. dispar 
varies considerablv. Whether this observation reflects 
small-scale rather -than large-scale geographical differ- 
ences in the distribution of E. histolytica cannot be 
answered at this time. In order to increase the epi- 
demiological understanding of amoebiasis, this issue 
needs urgently to be further investigated. 
The ‘Entamoeba’ test and the PCR assay showed 
only limited agreement in detecting infections (46.5%). 
PCR detected a substantially higher number of E. 
histoZytica/E. dispar infections than the ‘Entamoeba 
test’. Possibly the additional cases detected by PCR 
reflected the low sensitivity of a single examination 
using the other test. However, technical problems with 
the PCR technique cannot simply be excluded. This 
technique is potentially prone to cross-contamination 
due to its power to amplify minute traces of target 
DNA. To test for possible contamination, our samples 
were retested twice by PCR by an independent investi- 
gator using additional controls, but we could not find a 
problem with the assay. However, contamination can 
occur between the field and the laboratory during 
sample handling or DNA preparation and this cannot 
be traced later. 
When the PCR assay was taken as the standard, the 
‘Histolytica’ ELISA antigen detection test showed high 
efficiency (98.4%). However, the 2 tests disagreed with 
3 samples which were positive for E. histolytica by either 
PCR or ELISA (Table 3). In contrast, another study 
also using the TechLab specific ELISA and a PCR 
assay for the diagnosis of E. histolytica in stool samples, 
found a correlation of 84% between the 2 tests (HAQUE 
et al., 1998). Our findings concerning E. histolytica 
infections are difficult to interpret because of the small 
number of infections. Despite a rather large initial 
sample size we failed to detect many such infections 
because of the unexpectedly low E. histoZyticalE. dispar 
ratio. 
In conclusion, this study produced valuable data in 
relation to the occurrence of E. disaar and E. histolvtica 
in communities in sub-Saharan At&a. While the pre- 
valence of the species complex was high, the prevalence 
of E. histolytica was low. This might explain the paradox 
of the low amount of amoebiasis morbidity reported by 
health services on the African continent despite a high 
apparent microscopical infection rate. Field testing 
with the new generation of ELISA kits proved to be 
clearly superior to microscopy. Because of the small 
number of E. histolytica cases in our sample the in- 
tended comparison of test performance between the 
‘Histolytica’ ELISA and the PCR did not result is a 
clear conclusion about which test is superior. However, 
unlike the PCR, the ELISA proved to be easy to use in 
the field and, if its high diagnostic performance is 
confirmed, it might well become the standard tech- 
nique for large-scale field screening. 
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